Cartesian Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 48
EBIT TTM (mln): -264
index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 3 6 8 0 1 7 17 85 111 26 39
Przychód Δ r/r 0.0% 97.7% 34.5% -97.4% 336.2% 639.4% 148.6% 412.6% 30.2% -76.5% 49.6%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 98.2% 94.0% 100.0%
EBIT (mln) -15 -25 -35 -64 -65 -52 -57 -5 15 -86 -44
EBIT Δ r/r 0.0% 64.3% 37.0% 84.0% 1.9% -19.3% 8.3% -91.9% -416.2% -694.4% -49.2%
EBIT (%) -506.5% -421.0% -428.9% -30813.5% -7200.7% -785.6% -342.4% -5.4% 13.1% -332.3% -112.8%
Koszty finansowe (mln) 1 1 1 1 1 2 2 3 3 3 0
EBITDA (mln) -11 -23 -34 -63 -63 -50 -56 -3 16 -85 -76
EBITDA(%) -377.1% -403.6% -419.0% -30451.2% -7092.7% -755.2% -337.4% -3.9% 14.6% -326.4% -195.3%
Podatek (mln) 0 0 0 0 0 0 2 16 -1 -19 0
Zysk Netto (mln) -13 -25 -36 -65 -65 -55 -69 -26 35 -220 -77
Zysk netto Δ r/r 0.0% 95.5% 43.8% 80.4% 0.0% -15.3% 24.4% -62.7% -237.7% -721.0% -64.8%
Zysk netto (%) -423.7% -418.8% -448.0% -31556.0% -7235.4% -829.0% -415.0% -30.2% 31.9% -844.9% -199.0%
EPS -38.17 -40.5 -103.52 -95.94 -87.55 -36.46 -20.42 -6.74 7.33 -42.58 -0.5
EPS (rozwodnione) -38.17 -40.5 -103.52 -95.94 -87.55 -36.46 -20.42 -6.74 2.98 -42.58 -0.5
Ilośc akcji (mln) 0 1 0 1 1 2 3 4 5 5 155
Ważona ilośc akcji (mln) 0 1 0 1 1 2 3 4 5 5 155
Waluta USD USD USD USD USD USD USD USD USD USD USD